N-glycosylation of FGFR2 was shown to regulate cellular trafficking and autoactivation of the receptor [12], and mutations in FGFR2 and FGFR3 that disrupt N-glycosylation were linked with craniosynostosis syndromes [11, 12]. This evidence concerns the gene FGFR2 and craniosynostosis.